Malignant Brain Stem Neoplasm — Trials

Malignant Brain Stem Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 49
Recruiting: 26
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Nationwide Children's Hospital
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04911621	Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma(ADDICT-pedGLIO)	completed	Phase 1 / Phase 2	10	University Hospital, AntwerpOTHER	1	Jun 5, 2026	clinicaltrials
NCT02960230	H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas	completed	Phase 1 / Phase 2	50	Sabine Mueller, MD, PhDOTHER	2	Jan 22, 2025